Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_abe3c2b8086a49c1c85f86129d98df60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a819eda0adf22936a52362eeebb9fb4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c0dead48cf5d06b9637aff4863f2b9a |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
filingDate |
2005-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce1c4768d35f90c7061f5a3032742929 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87bcfe8d5d2a112289a14f035fec3e7c |
publicationDate |
2005-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2005091823-A2 |
titleOfInvention |
The use of lunasin peptide as a transcriptional activator to prevent cancer and related methods for treatment, monitoring and prognosis |
abstract |
Gene expression profiles produced in response to lunasin exposure, wherein such gene expression profiles correlate with anti-neoplastic activity, methods for using such expression profiles for screening potential anti-neoplastic agents, and methods for treatment and monitoring of a subject having a neoplastic disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009051662-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010291044-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9678060-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009051662-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103933548-A |
priorityDate |
2004-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |